Profits crashing for some med tech giants

Qmed has put together the 5 biggest drops in profit for med tech companies in 2014, and it's not looking good for device giants so far this year. Stryker's ($SYK) profit has plummeted by a whopping 77% over its metal-on-metal hip implant lawsuit costs, while Intuitive Surgical ($ISRG) follows next with a 76.6% drop in profit and the FDA crying foul over its power morcellators. Edwards Lifesciences' ($EW) profit is down by 53.1% because of its ongoing TAVR patent war with Medtronic ($MDT), which has brought Medtronic down by 53.8%. Finally, there's Abbott ($ABT), which has seen profits drop by 31.1%--analysts say it's because of the company's voluntary recall of baby formula in China. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.